Harrow Health Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.41 Billion, with shareholders equity totaling $52.09 Millions.
The company employs approximately 125 people and operates in the Health sector, within the Main Medications industry.
Over the past 12 months, Harrow Health Inc. reported $272.30 Millions in revenue, generating net income of $-5.13 Millions.
Key financial metrics include a P/E ratio of -275.73, a price-to-book (P/B) ratio of 27.16, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker HROW.